| Name
|
Enfuvirtide; T-20
|
| Code
|
[159519-65-0]
|
| The alias
|
Enfuvirtide; T-20
|
| Sequence (single letter abbreviation)
|
Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-NH2
|
| Sequence (three-letter abbreviation)
|
Ac-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2?(trifluoroacetate salt)
|
| A basic description
|
Virus replication inhibitory peptide a potent specific inhibitor of the replication of paramyxovirus and myxovirus, by inhibiting the membrane fusing activity of a viral glycoprotein.
|
| solubility
|
|
| The molecular weight
|
4491.94
|
| Chemical formula
|
C204H301N51O64
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
H.B.Fung and Y.Guo, Clin. Ther., 26, 352 (2004)
R.Manfredi and S.Sabbatani, Curr. Med. Chem., 13, 2369 (2006)
J.Ruof et al., Clin. Drug Investig., 27, 469 (2007)
A.Streinu-Cercel et al., HIV Clin. Trials, 9, 375 (2008)
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
|